NEPH News and Press, Nephros Inc. From 04/05/21

Gainers: Chembio Diagnostics (CEMI) +61%.AeroCentury (ACY) +59%.Xcel Brands (XELB) +54%.dMY Technology (DMYD) +34%.Performant Financial (PFMT) +33%.Nephros (NEPH) +27%.Nano-X Imaging (NNOX) +26%.Regional Health Properties (RHE) +24%.Leaf Group (LEAF) +21%.Bluegreen Vacatio...

Nephros (NEPH): Q1 Revenue to be  $2.7M (+8% Y/Y) and (+17% Q/Q) vs. consensus of $2.35M.Nephros ended the Q1 with ~$8.1M in cash on a consolidated basis."These results, represented by strength in all of our filtration markets – Healthcare, Dialysis, and Commercial – reflec...

Anticipates Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ, April 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions t...

SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executiv...

Nephros, Inc. (NEPH) Q4 2020 Earnings Conference Call March 01, 2021 04:30 PM ET Company Participants Kirin Smith - PCG Advisory Group, Investor Relations Andy Astor - Chief Executive Officer Wes Lobo - Chief Marketing Officer Conference Call Participants Marc Wiesenberger - B Riley FBR Antho...

Nephros (NEPH): Q4 net loss of $0.76M.Revenue of $2.3M (-28.1% Y/Y) beats by $0.01M.Press Release For further details see: Nephros beats on revenue

Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third Quarter Full Year Revenue $8.6 million, Down 17% Against Prior Year SOUTH ORANGE, NJ, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq:NEPH), a leading water technology comp...

SOUTH ORANGE, NJ - ( NewMediaWire ) - February 22, 2021 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter and full year 2020 fina...

SOUTH ORANGE, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the appointment of Wes Lobo ...

Nephros (NEPH) more than doubled over the past five-year period, outperforming XLV, the Health Care Select Sect SPDR ETF.However, that has not deterred B Riley Securities to initiate the coverage on the stock with a buy rating.Based on a 6.5x of FY22E EV/sales multiple, the price target at $1...